THE USE OF NASAL MUPIROCIN OINTMENT TO PREVENT STAPHYLOCOCCUS-AUREUS BACTEREMIAS IN HEMODIALYSIS-PATIENTS - AN ANALYSIS OF COST-EFFECTIVENESS

被引：31
|
作者：
BOELAERT, JR
DEBAERE, YA
GEERNAERT, MA
GODARD, CA
VANLANDUYT, HW
机构：
[1] ALGEMEEN ZIEKENHUIS ST JAN,DEPT MICROBIOL,BRUGES,BELGIUM
[2] INST PASTEUR,LYSOTYPIE LAB,B-1040 BRUSSELS,BELGIUM
来源：
JOURNAL OF HOSPITAL INFECTION | 1991年 / 19卷
关键词：
MUPIROCIN; STAPHYLOCOCCUS-AUREUS; HEMODIALYSIS; BACTEREMIA;
D O I：
10.1016/0195-6701(91)90202-J
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
Nasal carriage of Staphylococcus aureus is a risk factor for the development of infections caused by S. aureus in haemodialysis patients. This study compared the incidence of bacteraemia caused by S. aureus during 6 months of use of nasal 2% calcium mupirocin ('Nasal Bactroban') 3-times a week for nasal carriers with the incidence observed previously in the same dialysis unit without the use of mupirocin. Nasal mupirocin led to the total eradication of nasal carriage of S. aureus, a 4·26-fold reduction in the incidence of S. aureus bacteraemia, and a substantial cost saving. After a cumulative experience of nasal mupirocin in haemodialysis patients of more than 43 patient-years, the development of mupirocin resistance was not observed. © 1991.
引用
收藏
页码：41 / 46
页数：6
相关论文
共 50 条
  • [31] Cost-Effectiveness of Preoperative Nasal Mupirocin Treatment in Preventing Surgical Site Infection in Patients Undergoing Total Hip and Knee Arthroplasty: A Cost-Effectiveness Analysis
    Courville, Xan F.
    Tomek, Ivan M.
    Kirkland, Kathryn B.
    Birhle, Marian
    Kantor, Stephen R.
    Finlayson, Samuel R. G.
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2012, 33 (02): : 152 - 159
  • [32] ATTEMPTS TO ERADICATE METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS FROM A LONG-TERM-CARE FACILITY WITH THE USE OF MUPIROCIN OINTMENT
    KAUFFMAN, CA
    TERPENNING, MS
    HE, XG
    ZARINS, LT
    RAMSEY, MA
    JORGENSEN, KA
    SOTTILE, WS
    BRADLEY, SF
    AMERICAN JOURNAL OF MEDICINE, 1993, 94 (04): : 371 - 378
  • [33] Control of a methicillin-resistant Staphylococcus aureus outbreak in a neonatal intensive care unit by unselective use of nasal mupirocin ointment
    Hitomi, S
    Kubota, M
    Mori, N
    Baba, S
    Yano, H
    Okuzumi, K
    Kimura, S
    JOURNAL OF HOSPITAL INFECTION, 2000, 46 (02) : 123 - 129
  • [34] Staphylococcus Aureus Prevention Strategies in Cardiac Surgery: A Cost-Effectiveness Analysis
    Hong, Jonathan C.
    Saraswat, Manoj K.
    Ellison, Trevor A.
    Magruder, J. Trent
    Crawford, Todd
    Gardner, Julia M.
    Padula, William V.
    Whitman, Glenn J.
    ANNALS OF THORACIC SURGERY, 2018, 105 (01): : 47 - 53
  • [35] Mupirocin prophylaxis to prevent Staphylococcus aureus infection in patients undergoing dialysis:: A meta-analysis
    Tacconelli, E
    Carmeli, Y
    Aizer, A
    Ferreira, G
    Foreman, MG
    D'Agata, EMC
    CLINICAL INFECTIOUS DISEASES, 2003, 37 (12) : 1629 - 1638
  • [36] STAPHYLOCOCCUS-AUREUS NASAL CARRIAGE ON CAPD PATIENTS - IS IT INDUCED OF FAVORED BY SUBCUTANEOUS USE OF EPO
    SELGAS, R
    CASTRO, MJ
    BAJO, MA
    FERNANDEZREYES, MJ
    LOPEZREVUELTA, K
    ROMERO, JR
    DEALVARO, F
    BORREGO, F
    RINON, C
    NEFROLOGIA, 1992, 12 : 106 - 110
  • [37] Predictive value and cost-effectiveness analysis of a rapid polymerase chain reaction for preoperative detection of nasal carriage of Staphylococcus aureus
    Shrestha, NK
    Shermock, KM
    Gordon, SM
    Tuohy, MJ
    Wilson, DA
    Cwynar, RE
    Banbury, MK
    Longworth, DL
    Isada, CM
    Mawhorter, SD
    Procop, GW
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2003, 24 (05): : 327 - 333
  • [38] A cost-effectiveness analysis of mupirocin and chlorhexidine gluconate for Staphylococcus aureus decolonization prior to hip and knee arthroplasty in Alberta, Canada compared to standard of care
    Elissa Rennert-May
    John Conly
    Stephanie Smith
    Shannon Puloski
    Elizabeth Henderson
    Flora Au
    Braden Manns
    Antimicrobial Resistance & Infection Control, 8
  • [39] A cost-effectiveness analysis of mupirocin and chlorhexidine gluconate for Staphylococcus aureus decolonization prior to hip and knee arthroplasty in Alberta, Canada compared to standard of care
    Rennert-May, Elissa
    Conly, John
    Smith, Stephanie
    Puloski, Shannon
    Henderson, Elizabeth
    Au, Flora
    Manns, Braden
    ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL, 2019, 8 (1)
  • [40] Clinical and economic effects of mupirocin calcium on preventing Staphylococcus aureus infection in hemodialysis patients: A decision analysis
    Bloom, BS
    Fendrick, AM
    Chernew, ME
    Patel, P
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 27 (05) : 687 - 694
12345